Expanding the Cardiovascular Product Lineup Through the Transfer of Rights to Warfarin
A theme focused on expanding the cardiovascular product lineup and creating synergies with existing generic drugs through the transfer of rights to Warfarin in the Japanese market.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.